Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (632)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
84
2022
280
13.530
 Why?
Ovarian Neoplasms
37
2024
453
2.920
 Why?
Papillomavirus Infections
18
2021
165
2.900
 Why?
Endometrial Neoplasms
34
2019
139
2.530
 Why?
Uterine Cervical Dysplasia
16
2017
50
2.530
 Why?
Carcinoma, Squamous Cell
31
2018
380
2.070
 Why?
Gene Expression Regulation, Neoplastic
18
2021
868
1.930
 Why?
Human papillomavirus 16
8
2019
46
1.810
 Why?
Female
189
2024
28542
1.590
 Why?
Gene Expression Profiling
9
2021
1100
1.590
 Why?
Papillomaviridae
16
2020
109
1.450
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
1030
1.350
 Why?
DNA Methylation
21
2020
588
1.340
 Why?
Genital Neoplasms, Female
10
2018
42
1.250
 Why?
Human papillomavirus 18
5
2019
10
1.240
 Why?
Genetic Predisposition to Disease
13
2024
549
1.150
 Why?
Humans
190
2024
54277
1.150
 Why?
Adult
92
2024
14279
1.120
 Why?
Neoplasm Staging
41
2019
788
1.070
 Why?
Middle Aged
99
2024
12962
1.060
 Why?
Adenocarcinoma
18
2018
428
1.040
 Why?
Polymorphism, Single Nucleotide
10
2019
541
0.990
 Why?
Fluorodeoxyglucose F18
15
2022
210
0.970
 Why?
MicroRNAs
7
2019
379
0.970
 Why?
Neoplasm Recurrence, Local
19
2024
643
0.970
 Why?
DNA-Binding Proteins
9
2021
480
0.960
 Why?
Carcinoma
12
2010
156
0.930
 Why?
Oncogene Proteins, Viral
4
2019
52
0.890
 Why?
Cervix Uteri
7
2017
54
0.830
 Why?
Repressor Proteins
4
2019
164
0.820
 Why?
Radiopharmaceuticals
14
2022
239
0.810
 Why?
Alphapapillomavirus
1
2021
15
0.790
 Why?
DNA, Viral
6
2019
149
0.770
 Why?
Cell Line, Tumor
18
2021
1503
0.740
 Why?
Immunologic Factors
2
2014
120
0.740
 Why?
Neoplasm Invasiveness
15
2020
287
0.720
 Why?
Genetic Markers
8
2017
116
0.700
 Why?
Neoplasms
8
2022
1340
0.700
 Why?
Genes, Tumor Suppressor
8
2007
89
0.690
 Why?
Immunoglobulins
3
2017
85
0.680
 Why?
Aged
70
2024
9984
0.680
 Why?
Neoplasm Proteins
10
2019
347
0.680
 Why?
Genomics
4
2018
309
0.650
 Why?
Gene Silencing
5
2018
126
0.650
 Why?
Biomedical Research
1
2022
244
0.640
 Why?
Vascular Endothelial Growth Factor A
2
2017
220
0.570
 Why?
Cisplatin
7
2022
346
0.550
 Why?
Proteomics
1
2019
345
0.550
 Why?
HLA-C Antigens
2
2018
4
0.540
 Why?
Aged, 80 and over
36
2024
3398
0.540
 Why?
Receptors, KIR
2
2018
15
0.540
 Why?
Promoter Regions, Genetic
12
2020
526
0.530
 Why?
Tumor Virus Infections
4
2006
45
0.520
 Why?
Ubiquitin Thiolesterase
2
2021
22
0.520
 Why?
Microsatellite Repeats
14
2007
46
0.510
 Why?
Positron-Emission Tomography
11
2013
317
0.510
 Why?
Lymph Nodes
10
2010
285
0.510
 Why?
Hysterectomy
15
2022
90
0.510
 Why?
Disease-Free Survival
17
2013
472
0.500
 Why?
Gynecologic Surgical Procedures
4
2010
30
0.500
 Why?
Granulosa Cell Tumor
2
2024
2
0.490
 Why?
Phenotype
4
2016
797
0.470
 Why?
Prognosis
19
2021
2074
0.460
 Why?
Chromosomes, Human, Pair 6
4
2007
15
0.460
 Why?
Lymphatic Metastasis
14
2019
258
0.450
 Why?
Alleles
5
2017
274
0.450
 Why?
Nuclear Proteins
8
2009
266
0.440
 Why?
Loss of Heterozygosity
10
2007
98
0.440
 Why?
Ovary
2
2008
105
0.430
 Why?
Membrane Proteins
3
2005
378
0.420
 Why?
Genotype
9
2018
606
0.410
 Why?
STAT3 Transcription Factor
3
2021
85
0.410
 Why?
Cell Movement
5
2021
264
0.410
 Why?
Peritoneal Neoplasms
4
2008
58
0.410
 Why?
Survival Analysis
14
2021
711
0.410
 Why?
Ultrasonic Therapy
3
2001
40
0.400
 Why?
Carcinoma, Endometrioid
6
2014
38
0.400
 Why?
Genes, p53
2
2010
62
0.400
 Why?
Cell Proliferation
6
2021
1069
0.380
 Why?
Uterine Neoplasms
5
2009
63
0.380
 Why?
Risk Factors
13
2019
3906
0.370
 Why?
Signal Transduction
8
2021
1742
0.370
 Why?
Ascites
2
2008
28
0.370
 Why?
Carboplatin
2
2009
59
0.370
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
13
0.360
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
23
0.360
 Why?
Mutation
12
2018
1415
0.360
 Why?
Cohort Studies
13
2024
1518
0.350
 Why?
Antineoplastic Agents
9
2014
1286
0.350
 Why?
Disease Progression
6
2020
866
0.350
 Why?
GTPase-Activating Proteins
1
2009
26
0.350
 Why?
Membrane Glycoproteins
2
2009
263
0.350
 Why?
Antibodies, Monoclonal
5
2021
548
0.350
 Why?
Base Sequence
8
2019
724
0.350
 Why?
DNA, Neoplasm
11
2006
168
0.340
 Why?
Matrix Metalloproteinase 9
1
2009
92
0.340
 Why?
Chromosomes, Human, Pair 11
3
2005
63
0.340
 Why?
Neoplasms, Glandular and Epithelial
3
2006
42
0.340
 Why?
Brachytherapy
9
2014
47
0.340
 Why?
Proto-Oncogene Proteins c-myc
2
2021
56
0.330
 Why?
Abdominal Neoplasms
1
2009
21
0.330
 Why?
Combined Modality Therapy
11
2010
691
0.330
 Why?
DNA Repair
11
2007
210
0.330
 Why?
Laser Coagulation
1
2009
28
0.330
 Why?
Retrospective Studies
33
2024
6511
0.320
 Why?
Drug Administration Schedule
10
2013
403
0.320
 Why?
Deoxycytidine
4
2006
30
0.320
 Why?
Homeodomain Proteins
2
2006
85
0.320
 Why?
Microsatellite Instability
5
2019
21
0.310
 Why?
RNA-Binding Proteins
2
2021
136
0.310
 Why?
Protozoan Proteins
1
2008
32
0.310
 Why?
Germ-Line Mutation
3
2024
62
0.310
 Why?
Laparoscopy
3
2022
187
0.310
 Why?
Kaplan-Meier Estimate
6
2019
491
0.310
 Why?
Drug Resistance, Neoplasm
6
2016
316
0.300
 Why?
Ovariectomy
7
2010
135
0.300
 Why?
Antigens, CD
2
2007
235
0.290
 Why?
Chromosomes, Human, Pair 3
4
2001
21
0.290
 Why?
SOXC Transcription Factors
2
2019
14
0.290
 Why?
Receptors, Estrogen
3
2024
141
0.280
 Why?
Heart Arrest
1
2009
162
0.280
 Why?
Topotecan
5
2013
19
0.280
 Why?
Polymerase Chain Reaction
9
2010
526
0.280
 Why?
POU Domain Factors
1
2006
1
0.280
 Why?
Vulvar Neoplasms
5
2002
53
0.270
 Why?
Registries
6
2010
553
0.270
 Why?
Neoplasm Metastasis
5
2021
250
0.270
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
456
0.270
 Why?
HeLa Cells
3
2021
283
0.270
 Why?
Anemia
3
2020
70
0.260
 Why?
Vaginal Smears
6
2006
31
0.260
 Why?
Survival Rate
10
2009
945
0.260
 Why?
Young Adult
7
2018
4298
0.250
 Why?
Breast Neoplasms
5
2018
1245
0.250
 Why?
Immunohistochemistry
12
2024
1090
0.250
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
655
0.240
 Why?
Chromosome Aberrations
1
2006
321
0.240
 Why?
Virus Integration
2
2021
9
0.240
 Why?
HSP70 Heat-Shock Proteins
1
2004
65
0.240
 Why?
Receptors, Progesterone
1
2024
63
0.230
 Why?
Receptors, Androgen
1
2024
51
0.230
 Why?
Cystadenocarcinoma, Papillary
2
2002
15
0.230
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.230
 Why?
Oncostatin M
2
2021
5
0.230
 Why?
Quinazolines
1
2003
38
0.230
 Why?
Antigens, Neoplasm
1
2004
165
0.220
 Why?
Polymorphism, Genetic
5
2018
195
0.220
 Why?
Genome-Wide Association Study
2
2017
188
0.220
 Why?
Small Cell Lung Carcinoma
1
2023
27
0.220
 Why?
Omentum
1
2002
14
0.220
 Why?
Case-Control Studies
7
2019
1205
0.210
 Why?
Chromosome Deletion
3
2000
149
0.210
 Why?
Tumor Microenvironment
2
2021
215
0.210
 Why?
Linkage Disequilibrium
3
2017
43
0.210
 Why?
Neoadjuvant Therapy
2
2022
119
0.210
 Why?
Proto-Oncogene Proteins c-akt
2
2014
166
0.210
 Why?
Treatment Outcome
23
2014
5558
0.210
 Why?
Antibodies, Monoclonal, Humanized
5
2013
238
0.210
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.200
 Why?
CA-125 Antigen
3
2008
17
0.200
 Why?
Base Pair Mismatch
5
2006
24
0.200
 Why?
Genetic Variation
4
2019
245
0.200
 Why?
Chemoradiotherapy
1
2022
42
0.200
 Why?
Suction
1
2001
20
0.200
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.200
 Why?
Postoperative Complications
3
2022
1060
0.200
 Why?
Radiotherapy, Conformal
2
2014
54
0.190
 Why?
Carcinoma in Situ
2
2013
75
0.190
 Why?
Colorectal Neoplasms
3
2002
246
0.190
 Why?
Proteins
5
2008
378
0.190
 Why?
Adaptor Proteins, Signal Transducing
8
2007
207
0.190
 Why?
Antimetabolites, Antineoplastic
2
2002
38
0.190
 Why?
Smoking
1
2005
553
0.190
 Why?
Fetofetal Transfusion
1
2020
6
0.190
 Why?
Polycythemia
1
2020
11
0.190
 Why?
Pregnancy, Twin
1
2020
8
0.190
 Why?
Gene Regulatory Networks
2
2019
117
0.190
 Why?
Minority Groups
1
2022
137
0.190
 Why?
Twins, Monozygotic
1
2020
18
0.190
 Why?
Lymph Node Excision
7
2019
142
0.180
 Why?
Radiotherapy
3
2010
141
0.180
 Why?
Genetic Diseases, Inborn
1
2000
27
0.180
 Why?
Sarcoma
3
2009
74
0.180
 Why?
Transcriptome
2
2020
345
0.180
 Why?
Receptor, erbB-3
1
2020
2
0.180
 Why?
Furin
1
2020
3
0.180
 Why?
Receptor, IGF Type 1
1
2020
19
0.180
 Why?
Phosphoproteins
2
2016
115
0.180
 Why?
Patient Satisfaction
2
2006
300
0.180
 Why?
HLA-DQ Antigens
1
2000
3
0.180
 Why?
Mice, Nude
4
2021
268
0.180
 Why?
RNA, Neoplasm
3
2007
49
0.170
 Why?
Tumor Cells, Cultured
7
2021
505
0.170
 Why?
Tomography, X-Ray Computed
7
2013
1239
0.170
 Why?
Prenatal Diagnosis
1
2020
114
0.170
 Why?
Students
1
2022
222
0.170
 Why?
Antibodies, Neoplasm
1
2019
35
0.170
 Why?
Papillomavirus E7 Proteins
2
2017
31
0.170
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
5
0.170
 Why?
Placenta
1
2020
134
0.170
 Why?
Adolescent
13
2018
6921
0.170
 Why?
Reproducibility of Results
2
2022
1281
0.160
 Why?
Indocyanine Green
1
2019
37
0.160
 Why?
Doxorubicin
4
2009
255
0.160
 Why?
Fallopian Tube Neoplasms
3
2008
14
0.160
 Why?
Follow-Up Studies
13
2019
2361
0.160
 Why?
Salvage Therapy
3
2008
146
0.160
 Why?
Cyclooxygenase 2
2
2017
46
0.160
 Why?
Decision Making
1
2001
290
0.160
 Why?
Sequence Analysis, DNA
1
2019
267
0.150
 Why?
HLA-DRB1 Chains
1
2017
4
0.150
 Why?
HLA-B Antigens
1
2017
6
0.150
 Why?
Lung Neoplasms
2
2023
640
0.150
 Why?
DNA Copy Number Variations
1
2018
111
0.150
 Why?
Metabolic Networks and Pathways
1
2018
99
0.150
 Why?
Transcription Factors
1
2021
635
0.150
 Why?
Receptors, Vitronectin
1
1997
1
0.150
 Why?
Carcinoma, Adenosquamous
3
2009
8
0.150
 Why?
Tumor Suppressor Proteins
3
2005
141
0.150
 Why?
Proto-Oncogene Proteins
5
2004
166
0.150
 Why?
DNA Mutational Analysis
9
2005
196
0.150
 Why?
Bayes Theorem
1
2017
119
0.150
 Why?
Adipose Tissue
1
2019
199
0.150
 Why?
Interleukin-10
1
2017
98
0.150
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
19
0.150
 Why?
In Situ Hybridization
3
2008
85
0.140
 Why?
Leukocytes, Mononuclear
1
2017
127
0.140
 Why?
Radiotherapy, Intensity-Modulated
2
2009
178
0.140
 Why?
Gene Expression Regulation, Viral
1
2017
51
0.140
 Why?
Protein Binding
1
2019
712
0.140
 Why?
Radiotherapy Dosage
8
2014
252
0.140
 Why?
Body Mass Index
3
2010
703
0.140
 Why?
Risk Assessment
9
2019
1343
0.140
 Why?
Taxoids
3
2006
42
0.140
 Why?
ROC Curve
1
2017
254
0.140
 Why?
Animals
10
2021
14665
0.140
 Why?
Carrier Proteins
7
2006
359
0.130
 Why?
Biopsy
5
2006
672
0.130
 Why?
Radiation Injuries
3
2008
150
0.130
 Why?
Estrogens
1
2017
247
0.130
 Why?
Colposcopy
3
2006
19
0.130
 Why?
Prospective Studies
10
2019
2539
0.130
 Why?
Wound Healing
2
2018
225
0.130
 Why?
Molecular Sequence Data
5
2009
954
0.130
 Why?
Carcinosarcoma
3
2019
18
0.130
 Why?
Ultrasonography, Doppler, Color
1
1995
38
0.130
 Why?
Cells, Cultured
2
2017
1720
0.130
 Why?
Double-Blind Method
1
2017
737
0.130
 Why?
Sensitivity and Specificity
4
2006
929
0.130
 Why?
Protein Kinase Inhibitors
2
2014
218
0.120
 Why?
Algorithms
1
2019
681
0.120
 Why?
Aneurysm
1
1995
40
0.120
 Why?
DNA Primers
2
2006
224
0.120
 Why?
Platinum Compounds
4
2008
10
0.120
 Why?
Phosphatidylinositol 3-Kinases
2
2014
146
0.120
 Why?
Dose-Response Relationship, Drug
6
2008
1516
0.120
 Why?
Mice
6
2021
6442
0.120
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
4
0.120
 Why?
Obesity
5
2010
1176
0.120
 Why?
Apoptosis
2
2021
1294
0.120
 Why?
Cyclohexanones
1
2014
7
0.120
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
15
0.120
 Why?
Camptothecin
3
2010
18
0.120
 Why?
Embolization, Therapeutic
1
1995
96
0.120
 Why?
TOR Serine-Threonine Kinases
1
2014
83
0.120
 Why?
Transcriptional Activation
2
2019
135
0.120
 Why?
Genetic Association Studies
1
2014
131
0.110
 Why?
Introns
1
2013
51
0.110
 Why?
Hypercalcemia
1
1993
35
0.110
 Why?
Paclitaxel
4
2007
97
0.110
 Why?
Decision Support Techniques
2
2010
74
0.110
 Why?
Chromosome Mapping
3
2005
177
0.110
 Why?
Pyridines
1
2014
141
0.110
 Why?
Cell Transformation, Neoplastic
2
2006
198
0.110
 Why?
Dermatologic Surgical Procedures
1
1992
37
0.110
 Why?
Brain Neoplasms
1
2016
297
0.100
 Why?
Keratinocytes
2
2006
95
0.100
 Why?
Groin
2
2002
16
0.100
 Why?
Tomography, Emission-Computed
4
2005
60
0.100
 Why?
Models, Genetic
1
2012
207
0.100
 Why?
Laser Therapy
1
1992
91
0.100
 Why?
Glucose
1
2014
366
0.100
 Why?
Pyrazoles
2
2023
115
0.100
 Why?
Exons
3
2007
104
0.100
 Why?
RNA, Messenger
4
2021
1218
0.100
 Why?
Infusions, Intravenous
4
2006
226
0.100
 Why?
Heterozygote
2
2004
88
0.100
 Why?
Condylomata Acuminata
1
1991
5
0.100
 Why?
Epithelium
2
2007
73
0.100
 Why?
Magnetic Resonance Imaging
3
2014
1635
0.100
 Why?
Goserelin
1
2010
1
0.100
 Why?
Models, Statistical
1
2012
247
0.100
 Why?
Decision Trees
1
2010
26
0.100
 Why?
Estrogen Antagonists
1
2010
21
0.100
 Why?
Ileal Diseases
1
1990
4
0.090
 Why?
Leiomyoma
1
1990
26
0.090
 Why?
Predictive Value of Tests
6
2010
995
0.090
 Why?
Polymorphism, Restriction Fragment Length
1
2010
70
0.090
 Why?
Epigenesis, Genetic
2
2019
400
0.090
 Why?
Restriction Mapping
3
2006
36
0.090
 Why?
Cell Differentiation
2
2009
717
0.090
 Why?
Gastrointestinal Hemorrhage
1
1990
85
0.090
 Why?
Skin Transplantation
1
1990
48
0.090
 Why?
Colonic Neoplasms
2
2004
170
0.090
 Why?
Diagnosis, Differential
3
2020
1140
0.090
 Why?
Maximum Tolerated Dose
5
2010
37
0.090
 Why?
Fluorouracil
2
2006
57
0.090
 Why?
Down-Regulation
4
2020
382
0.090
 Why?
Endometrium
3
2019
42
0.080
 Why?
Urinary Bladder Diseases
1
2009
19
0.080
 Why?
Age Factors
4
2006
1191
0.080
 Why?
Lymphatic Vessels
1
2009
46
0.080
 Why?
Lasers, Gas
1
2009
7
0.080
 Why?
Embolism, Air
1
2009
13
0.080
 Why?
Genome, Human
2
2008
128
0.080
 Why?
Vaginal Neoplasms
2
2005
4
0.080
 Why?
Intestinal Diseases
1
2009
37
0.080
 Why?
Adenocarcinoma, Clear Cell
3
2019
35
0.080
 Why?
Fluorine Radioisotopes
1
2008
26
0.080
 Why?
Primary Ovarian Insufficiency
1
2008
4
0.080
 Why?
Transcription, Genetic
4
2019
434
0.080
 Why?
Infertility, Female
1
2008
21
0.080
 Why?
Eimeria
1
2008
3
0.080
 Why?
Haplotypes
2
2017
91
0.080
 Why?
Polyethylene Glycols
2
2006
103
0.080
 Why?
Ubiquitin
1
2008
51
0.080
 Why?
Up-Regulation
2
2020
491
0.080
 Why?
Tumor Burden
2
2021
135
0.080
 Why?
Cricetinae
1
2008
209
0.080
 Why?
Expressed Sequence Tags
1
2007
12
0.080
 Why?
Cell Cycle Proteins
1
2009
193
0.080
 Why?
Angiogenesis Inhibitors
2
2006
197
0.080
 Why?
Infusion Pumps
1
1987
14
0.080
 Why?
Fluorescent Antibody Technique
1
2007
128
0.080
 Why?
Diagnostic Imaging
1
2009
183
0.080
 Why?
Microdissection
1
2007
23
0.080
 Why?
Precancerous Conditions
2
2005
91
0.070
 Why?
MutS Homolog 2 Protein
5
2007
16
0.070
 Why?
Stromal Cells
1
2007
77
0.070
 Why?
Pelvic Floor
1
2007
47
0.070
 Why?
Aorta
3
2005
174
0.070
 Why?
Organ Specificity
2
2018
124
0.070
 Why?
Codon
2
2003
50
0.070
 Why?
Lasers
1
2007
121
0.070
 Why?
Models, Biological
2
2008
806
0.070
 Why?
RNA, Double-Stranded
1
2006
23
0.070
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
20
0.070
 Why?
Neutropenia
1
2007
120
0.070
 Why?
Tissue Fixation
1
2006
39
0.070
 Why?
Recombinant Proteins
1
2008
538
0.070
 Why?
Intestinal Perforation
2
2006
26
0.070
 Why?
Specimen Handling
1
2006
62
0.070
 Why?
Pulmonary Embolism
1
1987
103
0.070
 Why?
Protein Kinases
1
2006
80
0.070
 Why?
Chromosomes, Artificial, Yeast
3
2000
6
0.070
 Why?
Head and Neck Neoplasms
2
2016
337
0.070
 Why?
Endometrial Hyperplasia
2
2002
14
0.070
 Why?
Papillomavirus Vaccines
1
2006
61
0.070
 Why?
Proportional Hazards Models
4
2010
420
0.060
 Why?
Abdomen
1
2006
87
0.060
 Why?
Recurrence
4
2010
694
0.060
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Probability
4
2007
181
0.060
 Why?
Neovascularization, Pathologic
1
2006
168
0.060
 Why?
Terminal Care
1
2005
53
0.060
 Why?
Quinolines
1
2004
39
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
55
0.060
 Why?
Cell Adhesion Molecules
1
2005
85
0.060
 Why?
Amyloid
1
2004
29
0.060
 Why?
Tumor Suppressor Protein p53
1
2006
249
0.060
 Why?
Male
11
2018
27576
0.060
 Why?
Tissue Distribution
1
2004
178
0.060
 Why?
Genes, Viral
1
2003
40
0.060
 Why?
Lactones
1
2003
26
0.060
 Why?
Abdomen, Acute
1
2003
6
0.060
 Why?
Thrombospondins
1
2003
8
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
302
0.060
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
58
0.060
 Why?
Pyrimidinones
1
2023
20
0.060
 Why?
Biopsy, Needle
4
2006
197
0.060
 Why?
RNA, Viral
2
2016
128
0.060
 Why?
Obesity, Morbid
1
2004
86
0.060
 Why?
Neoplasms, Second Primary
1
2004
76
0.060
 Why?
Fibroma
1
2003
42
0.060
 Why?
Radiotherapy, Adjuvant
3
2010
66
0.050
 Why?
Congenital Abnormalities
1
2004
113
0.050
 Why?
Uterine Hemorrhage
1
2002
12
0.050
 Why?
Age of Onset
2
2004
112
0.050
 Why?
Clinical Competence
1
2006
451
0.050
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
DNA, Ribosomal
1
2002
26
0.050
 Why?
Blood Transfusion, Autologous
1
2002
4
0.050
 Why?
PTEN Phosphohydrolase
2
2019
59
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
392
0.050
 Why?
Acridines
1
2002
5
0.050
 Why?
Genital Diseases, Female
1
2002
25
0.050
 Why?
Medical History Taking
1
2002
51
0.050
 Why?
Complementary Therapies
1
2002
25
0.050
 Why?
Medical Records
1
2002
92
0.050
 Why?
AU Rich Elements
1
2021
1
0.050
 Why?
Blood Donors
1
2002
36
0.050
 Why?
Family Health
1
2002
88
0.050
 Why?
Pregnancy
3
2020
2698
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
 Why?
Postmenopause
1
2002
105
0.050
 Why?
RNA Stability
1
2021
25
0.050
 Why?
Cytokine Receptor gp130
1
2021
13
0.050
 Why?
Receptors, Transforming Growth Factor beta
1
2001
26
0.050
 Why?
3' Untranslated Regions
1
2021
55
0.050
 Why?
Lymphatic Irradiation
1
2001
1
0.050
 Why?
Blotting, Northern
2
2001
120
0.050
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
28
0.050
 Why?
Blotting, Southern
3
2002
47
0.050
 Why?
Xenograft Model Antitumor Assays
1
2021
222
0.050
 Why?
Phosphoric Monoester Hydrolases
1
2000
22
0.050
 Why?
Uganda
1
2020
37
0.050
 Why?
Blood Vessels
1
2001
76
0.050
 Why?
Equipment Design
1
2001
314
0.050
 Why?
Risk Management
1
2000
34
0.050
 Why?
Catheterization, Central Venous
1
2001
101
0.050
 Why?
Internship and Residency
1
2006
494
0.050
 Why?
Physical Chromosome Mapping
1
2000
9
0.050
 Why?
Isoenzymes
1
2001
183
0.050
 Why?
Incidence
3
2007
1077
0.050
 Why?
Quality Improvement
1
2022
236
0.050
 Why?
Logistic Models
2
2017
985
0.040
 Why?
beta Karyopherins
1
2019
4
0.040
 Why?
Interviews as Topic
1
2001
310
0.040
 Why?
Acid Anhydride Hydrolases
1
1999
15
0.040
 Why?
Patient Discharge
1
2022
353
0.040
 Why?
Cell Survival
1
2021
671
0.040
 Why?
DNA Repair Enzymes
1
1999
50
0.040
 Why?
Adenosine Triphosphatases
1
1999
92
0.040
 Why?
Cell Nucleus
1
2019
210
0.040
 Why?
Molecular Targeted Therapy
1
2019
126
0.040
 Why?
Pregnancy Outcome
1
2020
244
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
 Why?
Regression Analysis
3
2006
443
0.040
 Why?
Coloring Agents
1
2019
81
0.040
 Why?
Cross-Sectional Studies
1
2024
1701
0.040
 Why?
Cystadenocarcinoma, Serous
1
2019
71
0.040
 Why?
Histone Demethylases
1
2018
16
0.040
 Why?
Gene Dosage
1
2018
86
0.040
 Why?
Th1-Th2 Balance
1
2018
2
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2018
50
0.040
 Why?
Leptin
1
2019
147
0.040
 Why?
Major Histocompatibility Complex
1
2017
13
0.040
 Why?
Genotyping Techniques
1
2017
24
0.040
 Why?
Databases, Genetic
1
2018
96
0.040
 Why?
Estradiol
1
2019
241
0.040
 Why?
Receptors, Collagen
1
1997
3
0.040
 Why?
Receptors, Fibronectin
1
1997
5
0.040
 Why?
Chemokines
1
2017
95
0.040
 Why?
Coculture Techniques
1
2017
152
0.040
 Why?
Integrins
1
1997
34
0.040
 Why?
Transforming Growth Factor beta
1
2018
161
0.040
 Why?
Interferon-gamma
1
2018
201
0.040
 Why?
Child
4
2018
7434
0.040
 Why?
Chemotherapy, Adjuvant
2
2010
121
0.040
 Why?
Mass Screening
1
2000
371
0.040
 Why?
Quality-Adjusted Life Years
2
2010
72
0.040
 Why?
Diet, High-Fat
1
2019
224
0.040
 Why?
Time Factors
4
2010
3211
0.040
 Why?
Hepatitis Viruses
1
2016
2
0.040
 Why?
Longitudinal Studies
1
2019
735
0.040
 Why?
Herpesviridae
1
2016
19
0.030
 Why?
Epithelial Cells
2
2006
257
0.030
 Why?
Host-Pathogen Interactions
1
2017
135
0.030
 Why?
Viruses
1
2016
22
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
45
0.030
 Why?
DNA Replication
1
1997
159
0.030
 Why?
Plasmids
2
2001
184
0.030
 Why?
Cost-Benefit Analysis
2
2010
301
0.030
 Why?
Central Nervous System Neoplasms
1
2016
65
0.030
 Why?
Sequence Analysis, RNA
1
2016
103
0.030
 Why?
Mice, Transgenic
1
2017
637
0.030
 Why?
Electrosurgery
1
1995
12
0.030
 Why?
Fibroblasts
1
2017
368
0.030
 Why?
Macrophages
1
2018
400
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
CpG Islands
2
2008
116
0.030
 Why?
Prostatic Neoplasms
1
1998
414
0.030
 Why?
Arteries
1
1995
98
0.030
 Why?
Computational Biology
1
2016
229
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
19
0.030
 Why?
Treatment Failure
2
2008
130
0.030
 Why?
Cytokines
1
2017
690
0.030
 Why?
Multivariate Analysis
2
2009
642
0.030
 Why?
Missouri
2
2006
65
0.030
 Why?
Organs at Risk
1
2014
72
0.030
 Why?
Inclusion Bodies
1
1993
23
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
26
0.030
 Why?
Cell Division
2
1994
341
0.030
 Why?
Cell Death
1
2014
226
0.030
 Why?
Imaging, Three-Dimensional
1
2014
161
0.030
 Why?
Risk
2
2004
340
0.030
 Why?
Skin Physiological Phenomena
1
1992
15
0.030
 Why?
Epidermis
1
1992
28
0.030
 Why?
Guinea Pigs
1
1992
91
0.030
 Why?
Pelvis
2
2004
75
0.030
 Why?
Pedigree
2
2004
130
0.030
 Why?
Deoxyglucose
1
2012
36
0.030
 Why?
Regeneration
1
1992
76
0.030
 Why?
Colectomy
1
1992
32
0.030
 Why?
Computer Simulation
1
2012
326
0.020
 Why?
Premenopause
1
2010
27
0.020
 Why?
Sequence Deletion
2
2003
79
0.020
 Why?
Staurosporine
1
2010
12
0.020
 Why?
Pilot Projects
2
2004
779
0.020
 Why?
Amino Acid Sequence
2
2003
729
0.020
 Why?
Anastomosis, Surgical
1
1990
73
0.020
 Why?
Molecular Weight
1
1990
97
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
68
0.020
 Why?
Remission Induction
1
2010
219
0.020
 Why?
ras Proteins
2
2001
68
0.020
 Why?
Cicatrix
1
1990
43
0.020
 Why?
Hemoglobins
1
1990
119
0.020
 Why?
Staining and Labeling
1
1990
104
0.020
 Why?
Chi-Square Distribution
1
2010
311
0.020
 Why?
Perioperative Care
1
2009
43
0.020
 Why?
Urinary Incontinence
1
2009
40
0.020
 Why?
Organoplatinum Compounds
1
2008
15
0.020
 Why?
Gene Knockdown Techniques
1
2009
113
0.020
 Why?
Vinblastine
1
2008
41
0.020
 Why?
Fetus
1
1990
231
0.020
 Why?
Life Style
1
2009
152
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
210
0.020
 Why?
Emotions
1
2009
173
0.020
 Why?
Demography
1
2007
107
0.020
 Why?
Cadherins
1
2007
72
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
150
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
Cell Line
1
1990
1125
0.020
 Why?
Waxes
1
2006
1
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
18
0.020
 Why?
DNA Mismatch Repair
1
2006
20
0.020
 Why?
NIH 3T3 Cells
1
2006
53
0.020
 Why?
Skin
1
1990
441
0.020
 Why?
Immunoenzyme Techniques
2
2001
160
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
14
0.020
 Why?
Chromosomal Instability
1
2006
17
0.020
 Why?
Neoplasm, Residual
1
2007
167
0.020
 Why?
Cryopreservation
1
2006
33
0.020
 Why?
Genome, Viral
1
2006
88
0.020
 Why?
Nurse Practitioners
1
2006
45
0.020
 Why?
Mutation, Missense
1
2006
107
0.020
 Why?
Analysis of Variance
1
2007
639
0.020
 Why?
Gynecology
1
2006
50
0.020
 Why?
Transfection
1
2006
397
0.020
 Why?
Ovarian Cysts
1
2005
4
0.020
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
 Why?
Early Diagnosis
1
2006
91
0.020
 Why?
Medical Futility
1
2005
11
0.020
 Why?
Cyclophosphamide
1
2006
170
0.020
 Why?
Gene Expression
1
2008
661
0.020
 Why?
Triage
1
2006
72
0.020
 Why?
Leiomyosarcoma
1
2005
26
0.020
 Why?
Cytodiagnosis
1
2005
44
0.020
 Why?
Hospice Care
1
2005
29
0.020
 Why?
Health Services
1
2005
77
0.020
 Why?
Obstetrics
1
2006
89
0.020
 Why?
Phosphorylation
1
2006
598
0.020
 Why?
Lymphatic System
1
2004
15
0.020
 Why?
Penetrance
1
2004
7
0.020
 Why?
Area Under Curve
1
2004
195
0.020
 Why?
Microscopy, Electron, Transmission
1
2004
83
0.020
 Why?
Calcification, Physiologic
1
2004
44
0.010
 Why?
Laparotomy
1
2004
35
0.010
 Why?
Bryostatins
1
2003
1
0.010
 Why?
Macrolides
1
2003
16
0.010
 Why?
Genomic Instability
1
2004
96
0.010
 Why?
Thrombospondin 1
1
2003
7
0.010
 Why?
Ethanol
1
2006
363
0.010
 Why?
Genes, p16
1
2003
10
0.010
 Why?
Tamoxifen
1
2004
64
0.010
 Why?
Codon, Terminator
1
2003
8
0.010
 Why?
Frameshift Mutation
1
2003
17
0.010
 Why?
Confidence Intervals
1
2003
169
0.010
 Why?
Liposomes
1
2003
53
0.010
 Why?
Administration, Oral
1
2004
466
0.010
 Why?
Mutagenesis, Insertional
1
2003
31
0.010
 Why?
Palliative Care
1
2005
194
0.010
 Why?
Cytoskeletal Proteins
1
2003
57
0.010
 Why?
DNA Transposable Elements
1
2003
125
0.010
 Why?
Body Weight
1
2005
586
0.010
 Why?
Prevalence
1
2006
1021
0.010
 Why?
Physicians
1
2006
255
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
 Why?
beta Catenin
1
2003
102
0.010
 Why?
Retinoblastoma Protein
1
2002
22
0.010
 Why?
Reference Values
1
2003
355
0.010
 Why?
Ifosfamide
1
2002
8
0.010
 Why?
Documentation
1
2002
36
0.010
 Why?
Trans-Activators
1
2003
148
0.010
 Why?
Bleomycin
1
2002
38
0.010
 Why?
Hospitals, University
1
2002
85
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
76
0.010
 Why?
Equipment Failure
1
2001
67
0.010
 Why?
Age Distribution
1
2002
187
0.010
 Why?
Nucleic Acid Hybridization
2
1991
57
0.010
 Why?
Statistics, Nonparametric
1
2002
230
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
84
0.010
 Why?
Carcinoma, Small Cell
1
2001
28
0.010
 Why?
Genes, erbB-1
1
2001
9
0.010
 Why?
Outpatients
1
2002
123
0.010
 Why?
Radiography
1
2002
527
0.010
 Why?
Hospitalization
1
2005
711
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
109
0.010
 Why?
Genetic Linkage
1
2000
27
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
177
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
28
0.010
 Why?
DNA
1
2004
603
0.010
 Why?
Morbidity
1
2000
148
0.010
 Why?
Gene Deletion
1
2000
287
0.010
 Why?
Blotting, Western
1
2001
671
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
164
0.010
 Why?
Chromosomes, Bacterial
1
1998
17
0.010
 Why?
Cloning, Molecular
1
1998
212
0.010
 Why?
Infant
1
2006
3884
0.010
 Why?
Child, Preschool
1
2006
4203
0.010
 Why?
Drug Resistance, Multiple
1
1997
27
0.010
 Why?
Gene Frequency
1
1997
110
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
84
0.010
 Why?
United States
1
2007
5275
0.010
 Why?
Dimethyl Sulfoxide
1
1994
13
0.010
 Why?
Glycerol
1
1994
25
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
53
0.010
 Why?
Drug Carriers
1
1994
73
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
144
0.010
 Why?
Cell Cycle
1
1994
277
0.010
 Why?
Retroperitoneal Space
1
1991
32
0.010
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (632) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department